Benjamin Esque
Chief Executive Officer at Corstasis Therapeutics
Profile
Benjamin Esque is the founder of Corstasis Therapeutics.
Prior to founding Corstasis Therapeutics, he worked as a Director at NewBridge Global Ventures, Inc. from 2017 to 2018.
He also worked as a Manager-Sales at KOS Pharmaceuticals, Inc. Mr. Esque completed his undergraduate degree at the University of California.
Benjamin Esque active positions
| Companies | Position | Start |
|---|---|---|
Corstasis Therapeutics
 Corstasis Therapeutics BiotechnologyHealth Technology Corstasis Therapeutics develops outpatient therapeutic options for patients suffering from fluid overload problems. The company is based in Henderson, NV. The company was founded by Benjamin Esque and he has been the CEO since incorporation. | Chief Executive Officer | - |
Former positions of Benjamin Esque
| Companies | Position | End |
|---|---|---|
| NEWBRIDGE GLOBAL VENTURES, INC. | Director/Board Member | 2018-07-15 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Sales & Marketing | - |
Training of Benjamin Esque
| University of California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NewBridge Global Ventures, Inc.
 NewBridge Global Ventures, Inc. Agricultural Commodities/MillingProcess Industries NewBridge Global Ventures, Inc. engages in the cultivation, manufacture, and distribution of medical and recreational cannabis. It also offers cannabis online education and consulting services. The company was founded by Ulrik Moll, Michael Maze, Mads H. Frederiksen and Morten Krarup in May 1983 and is headquartered in Alameda, CA. | Process Industries |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Corstasis Therapeutics
Corstasis Therapeutics BiotechnologyHealth Technology Corstasis Therapeutics develops outpatient therapeutic options for patients suffering from fluid overload problems. The company is based in Henderson, NV. The company was founded by Benjamin Esque and he has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Benjamin Esque
